Cabozantinib and temozolomide in patients with unresectable or metastatic leiomyosarcoma and other soft tissue sarcomas: a multicentre, single-arm, lead-in phase 2 trial

The Lancet Oncology 2026

View at publisher
Authors: Varun Monga, Scott H. Okuno, Brian Van Tine, Seth M. Pollack, Mia Weiss, Angela C. Hirbe, Pedro Duarte Fernandes Andrade Viveiros, Brian C. Schulte, Steven Attia, Brittany L. Siontis, Mohammad Milhem, John A. Charlson
+6 more Steven Robinson, Oluwatimilehin Okunowo, Paul Henry Frankel, Doni Woo, Janet M. Yoon, Mark Agulnik
DOI: 10.1016/s1470-2045(25)00654-0
Cited by: 1
References: 26

Fields of Study & Subjects

Sarcoma Diagnosis and Treatment Angiogenesis and VEGF in Cancer Gastrointestinal Tumor Research and Treatment

Publication details

Journal / source
The Lancet Oncology
Publisher
Elsevier BV
Volume
27
Issue
2
Pages
223–232
Publication date
16 January 2026
Language
EN